Amniotic fluid embolism

Anesthesia and Analgesia

Volumn 108, Issue 5, 2009, Pages 1599-1602

  Gist, Richard S ^a   Stafford, Irene P ^b   Leibowitz, Andrew B ^a   Beilin, Yaakov ^a,c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; APROTININ; DOPAMINE; INOTROPIC AGENT; LYSINE DERIVATIVE; MILRINONE; NITRIC OXIDE; NORADRENALIN; PHENYLEPHRINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; VASOPRESSIN;

AMNION FLUID EMBOLISM; ASSISTED CIRCULATION; BLEEDING; CARDIOPULMONARY BYPASS; CLINICAL FEATURE; CLINICAL TRIAL; CRYOPRECIPITATE; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPNEA; EXTRACORPOREAL OXYGENATION; HUMAN; HYPOTENSION; INCIDENCE; INTENSIVE CARE; MENORRHAGIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEIZURE; TREATMENT OUTCOME; ANIMAL; EARLY DIAGNOSIS; FEMALE; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PREGNANCY; RISK FACTOR;

ANIMALS; COMBINED MODALITY THERAPY; EARLY DIAGNOSIS; EMBOLISM, AMNIOTIC FLUID; FEMALE; HUMANS; INCIDENCE; PATIENT CARE TEAM; PREGNANCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 65349084381     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31819e43a4     Document Type: Review

References (37)

1. Meyer JR. Embolia pulmonary amino caseosa. Bras Med 1926;2:301-3
2. Steiner PE, Lushbaugh C. Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexplained death in obstetrics. JAMA 1941;117:1245-54
3. Nagarsheth NP, Pinney S, Bassily-Marcus A, Anyanwu A, Friedman L, Beilin Y. Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism. Anesth Analg 2008;107:962-4
4. McDonnell NJ, Chan BO, Frengley RW. Rapid reversal of critical haemodynamic compromise with nitric oxide in a patient with amniotic fluid embolism. Int J Obstet Anesth 2007;16:269-73
5. Stanten RD, Iverson LI, Daugherty TM, Lovett SM, Terry C, Blumenstrock E. Amniotic fluid embolism causing catastrophic pulmonary vasoconstriction: diagnosis by trans-esophageal echocardiogram and treatment by cardiopulmonary bypass. Obstet Gynecol 2003;102:496-8
6. Hsieh YY, Chang CC, Li PC, Tsai HD, Tsai CH. Successful application of extracorporeal membrane oxygenation and intra-aortic counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol 2000;183:496-7
7. Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995;172:1158-67
8. Tuffnell DJ. United Kingdom amniotic fluid embolism register. BJOG 2005;112:1625-9
9. Morgan M. Amniotic fluid embolism. Anesthesia 1979;34:20-32
10. Gilbert WM, Danielsen B. Amniotic fluid embolism: decreased mortality in a population-based study. Obstet Gynecol 1999;93:973-7
11. Spence MR, Mason KG. Experimental amniotic fluid embolism in rabbits. Am J Obstet Gynecol 1974;119:1073-8
12. Stolte L, van Kessel H, Seelen J, Eskes T, Wagatsuma T. Failure to produce the syndrome of amniotic fluid embolism by infusion of amniotic fluid and meconium into monkeys. Am J Obstet Gynecol 1967;98:694-7
13. Petroianu GA, Altmannsberger SH, Maleck WH, Assmus HP, Friedberg C, Bergler WF, Rüfer R. Meconium and amniotic fluid embolism: effects on coagulation in pregnant mini-pigs. Crit Care Med 1999;27:348-55
14. Hankins GD, Snyder RR, Clark SL, Schwartz L, Patterson WR, Butzin CA. Acute hemodynamic and respiratory effects of amniotic fluid embolism in the pregnant goat model. Am J Obstet Gynecol 1993;168:1113-29
15. Clark SL, Pavlova Z, Greenspoon J, Horenstein J, Phelan JP. Squamous cells in the maternal pulmonary circulation. Am J Obst Gynecol 1986;154:104-6
16. Lee W, Ginsburg KA, Cotton DB, Kaufman RH. Squamous and throphoblastic cells in the maternal pulmonary circulation in-dentified by invasive hemodynamic monitoring during the peripartum period. Am J Obstet Gynecol 1986;155:999-1001
17. Walsh SW, Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 1993;169:1462-66
18. Scott JR, Beer AE, Guy LR, Liesch M, Elbert G. Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus ma-ternofetal bleeding. Obstet Gynecol 1977;49:9-14
19. Fineschi V, Gambassi R, Gherardi M, Turillazzi E. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase. Int J Legal Med 1998;111:238-43
20. Nishio H, Matsui K, Miyazaki T, Tamura A, Iwata M, Suzuki K. A fatal case of amniotic fluid embolism with elevation of serum mast cell tryptase. Forensic Sci Int 2002;126:53-6
21. Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses 2007;68:1019-25
22. Clark SL. New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv 1990;45:360-8
23. Clark SL, Montz FJ, Phelan JP. Hemodynamic alterations associated with amniotic fluid embolism: a reappraisal. Am J Obstet Gynecol 1985;151:617-21
24. Malhotra P, Agarwal R, Awasthi A, DAS A, Behera D. Delayed presentation of amniotic fluid embolism: lessons from a case diagnosed at autopsy. Respirology 2007;12:148-50
25. Lockwood CJ, Bach R, Guha A, Zhou XD, Miller WA, Nemerson Y. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 1991;165:1335-41
26. Estelles A, Gilabert J, Andres C, Espana F, Aznar J. Plasminogen activator inhibitor type 1 and type 2 in amniotic fluid during pregnancy. Thromb Haemost 1990;64:281-5
27. Karetsky M, Ramirez M. Acute respiratory failure in pregnancy: an analysis of 19 cases. Medicine (Baltimore) 1998;77:41-9
28. Verroust N, Zegdi R, Ciobotaru V, Tsatsaris V, Goffinet F, Fabiani JN, Mignon A. Ventricular fibrillation during termination of pregnancy. Lancet 2007;369:1900
29. Malay MB, Ashton JL, Dahl K, Savage EB, Burchell SA, Ashton RC Jr, Sciacca RR, Oliver JA, Landry DW. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med 2004;32:1327-31
30. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007;47:1564-72
31. Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost 2008;34:104-12
32. Prosper SC, Goudge CS, Lupo VR. Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. Obstet Gynecol 2007;109:524-5
33. Thomas GO, Dutton RP, Hemlock B, Stein DM, Hyder M, Shere-Wolfe R, Hess JR, Scalea TM. Thromboembolic complications associated with factor VIIa administration. J Trauma 2007:62:564-9
34. Stroup J, Haraway D, Beal JM. Aprotinin in the management of coagulopathy associated with amniotic fluid embolism. Pharmacotherapy 2006;26:689-93
35. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358:2319-31
36. Peng TC, Kickler TS, Bell WR, Haller E. Obstetric complications in a patient with Bernard-Soulier syndrome. Am J Obstet Gynecol 1991;165:425-6
37. Kriplani A, Kulshrestha V, Agarwal N, Diwakar S. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate. J Obstet Gynaecol 2006;26:673-8